Table 1 of
Cehofski, Mol Vis 2024; 30:17-35. Table 1 of
Cehofski, Mol Vis 2024; 30:17-35.
Table 1. Samples for proteomic analysis.
| Various | DME | Control | p-value |
|---|---|---|---|
| Number of samples (n) | 13* | 11 | |
| Patients (n) | 11 | ||
| Age (years) | 61.9±18.7 | 68.5±11.3 | 0.32 |
| Sex (M/F) | 5/8 | 5/6 | |
| BCVA (logMAR) | 0.48±0.25 | ||
| Central subfield thickness (µm) | 366.9±176.0 | ||
| Mild non-proliferative diabetic retinopathy (n) | 1 | ||
| Moderate non-proliferative diabetic retinopathy (n) | 3 | ||
| Severe non-proliferative diabetic retinopathy (n) | 3 | ||
| Proliferative diabetic retinopathy (n) | 6 | ||
| HbA1c (%) | 8.1±2.0 | ||
| Hypertension (n) | 10 | 2 | 0.012 |
| Hyperlipidemia (n) | 6 | 2 | 0.21 |
| Oral treatment (n) | 11 | ||
| Oral treatment and insulin (n) | 4 | ||
| Insulin, no oral treatment (n) | 0 | ||
| Creatinin mg/dl | 1.71±1.37 | 0.76±0.15 | 0.023 |